Chapel Hill, NC, United States of America

José L Boyer

This inventor holds 19 USPTO granted patents and 4 published patent applications and 3 EPO patents, primarily in Ophthalmic Pharmaceuticals. Top assignees: Inspire Pharmaceuticals, Inc., The University of North Carolina at Chapel Hill, Nicox Ophthalmics, Inc.. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: José L Boyer. Retrieved from https://idiyas.com/inventor/jose-l-boyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 36.8

 

Average Co-Inventor Count = 4.9

ph-index = 9

Forward Citations = 206(Granted Patents)


Company Filing History:


Years Active: 2005-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Fluticasone Propionate
Nanocrystals
Blepharitis Treatment
Cystic Fibrosis
Platelet Aggregation
P2Y6 Receptor Agonists
Ocular Hypertension
Degradation-Resistant Compounds
Non-Nucleotide Composition
Composition Methods
Lung Diseases
Sterile Ophthalmic Solutions
19 patents (USPTO):Explore Patents

Title: The Innovative Contributions of José L Boyer in Ophthalmic Treatments

Introduction

José L Boyer, based in Chapel Hill, North Carolina, is a prolific inventor known for his significant contributions to the field of ophthalmology. With a remarkable portfolio of 16 patents, Boyer's innovations primarily focus on treating eye inflammation conditions through advanced pharmaceutical formulations.

Latest Patents

Among his latest patents is a groundbreaking process for the preparation of sterile ophthalmic aqueous fluticasone propionate from nanocrystal suspensions. This innovative method results in sterile topical ophthalmic nanosuspensions that can effectively treat various eye conditions, including blepharitis, posterior blepharitis, Meibomian gland dysfunction, and dry eye. These nanosuspensions are administered topically to the eyelids, eyelashes, and eyelid margins, providing a targeted approach to eye care.

Another significant patent is related to a method for treating non-infectious, inflammatory chronic posterior blepharitis. This invention details a systematic approach for administrating a pharmaceutical formulation comprising azithromycin to alleviate symptoms and improve the condition over an extended period. Furthermore, it addresses the treatment of dry eye conditions secondary to blepharitis, highlighting the potential for better eye health management through his inventions.

Career Highlights

José L Boyer has made substantial impacts throughout his career, notably working with Inspire Pharmaceuticals, Inc. and the University of North Carolina at Chapel Hill. His involvement with these organizations underscores his commitment to advancing medical science and providing innovative solutions for eye-related health issues.

Collaborations

Boyer's journey has been enriched by collaborations with notable professionals in his field, including James G Douglass, III, and Sammy Ray Shaver. These partnerships reflect a collaborative spirit dedicated to scientific exploration and innovation, further enhancing the efficacy of ocular treatments.

Conclusion

José L Boyer's contributions to the field of ophthalmology exemplify the essence of innovation and dedication to improving patient care. His numerous patents stand as a testament to his ingenuity and commitment to tackling complex health challenges. As he continues to influence the realm of ocular health, his work inspires future inventors and researchers in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…